Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurosyphilis in HIV-infected patients.
Bordón J, Martínez-Vázquez C, Alvarez M, Miralles C, Ocampo A, de la Fuente-Aguado J, Sopeña-Perez Arguelles B. Bordón J, et al. Among authors: miralles c. Eur J Clin Microbiol Infect Dis. 1995 Oct;14(10):864-9. doi: 10.1007/BF01691492. Eur J Clin Microbiol Infect Dis. 1995. PMID: 8605899
HIV-1 subtype G and BG recombinant viruses in Spanish natives: evidence of characteristic mutations in reverse transcriptase and protease.
Pérez-Alvarez L, Thomson MM, Villahermosa ML, de Parga EV, Rodríguez A, Cuevas MT, Delgado E, Manjón N, Miralles C, Medrano L, Taboada JA, Nájera R. Pérez-Alvarez L, et al. Among authors: miralles c. AIDS. 2001 Sep 28;15(14):1907-10. doi: 10.1097/00002030-200109280-00031. AIDS. 2001. PMID: 11579264 No abstract available.
Identification of a newly characterized HIV-1 BG intersubtype circulating recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure.
Delgado E, Thomson MM, Villahermosa ML, Sierra M, Ocampo A, Miralles C, Rodríguez-Pérez R, Diz-Aren J, Ojea-de Castro R, Losada E, Cuevas MT, Vázquez-de Parga E, Carmona R, Pérez-Alvarez L, Medrano L, Cuevas L, Taboada JA, Nájera R. Delgado E, et al. Among authors: miralles c. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):536-43. doi: 10.1097/00126334-200204150-00016. J Acquir Immune Defic Syndr. 2002. PMID: 11981372
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
Ramos B, Núñez M, Rendón A, Berdún MA, Losada E, Santos I, Echevarría S, Ocampo A, Miralles C, Arazo P, Barreiro P, Romero M, Labarga P, Guardiola JM, Garcia-Samaniego J, Soriano V. Ramos B, et al. Among authors: miralles c. J Viral Hepat. 2007 Jun;14(6):387-91. doi: 10.1111/j.1365-2893.2006.00806.x. J Viral Hepat. 2007. PMID: 17501758 Clinical Trial.
Premature treatment discontinuation in HIV/HCV-coinfected patients receiving pegylated interferon plus weight-based ribavirin.
Soriano V, Miralles C, Berdún MA, Losada E, Aguirrebengoa K, Ocampo A, Arazo P, Cervantes M, de los Santos I, San Joaquín I, Echeverria S, Galindo MJ, Asensi V, Barreiro P, Sola J, Hernandez-Burruezo JJ, Guardiola J, Blanco F, Martin-Carbonero L, García-Samaniego J, Nuñez M; PRESCO Study Group. Soriano V, et al. Among authors: miralles c. Antivir Ther. 2007;12(4):469-76. Antivir Ther. 2007. PMID: 17668555 Clinical Trial.
188 results